Page last updated: 2024-12-08

bruceine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bruceine A: quassinoid which inhibits protein synthesis & DNA synthesis in cells; RN given refers to (11 beta,12 alpha,15 beta)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160006
CHEMBL ID250451
CHEBI ID189511
SCHEMBL ID5928607
MeSH IDM0083779

Synonyms (19)

Synonym
nsc310616
brucein a
nsc-310616
25514-31-2
picras-3-en-21-oic acid,20-epoxy-3,11,12-trihydroxy-15-(3-methyl-1-oxobutoxy)-2,16-dioxo-, methyl ester, (11.beta.,12.alpha.,15.beta.)-
isobruceine a
CHEMBL250451
methyl (1r,2s,3r,6r,8r,13s,14r,15r,16s,17s)-10,15,16-trihydroxy-9,13-dimethyl-3-(3-methylbutanoyloxy)-4,11-dioxo-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-9-ene-17-carboxylate
CHEBI:189511
bruceine a
nsc 310616
picras-3-en-21-oic acid, 13,20-epoxy-3,11,12-trihydroxy-15-(3-methyl-1-oxobutoxy)-2,16-dioxo-, methyl ester, (11beta,12alpha,15beta)-
SCHEMBL5928607
HY-N0841
AKOS030526754
mfcd28167765
MS-29680
dihydrobrusatol
DTXSID901318520

Research Excerpts

Overview

Bruceine A is a natural quassinoid compound extracted from the fruit of the Traditional Chinese Medicine Brucea javanica (L.) Merr.

ExcerptReferenceRelevance
"Bruceine A is a natural quassinoid compound extracted from the fruit of the Traditional Chinese Medicine Brucea javanica (L.) Merr. "( Bruceine A protects against diabetic kidney disease via inhibiting galectin-1.
Li, H; Li, Y; Lin, S; Qiu, Q; Ren, H; Shen, J; Wang, X; Wang, Z; Zhao, X; Zheng, L, 2022
)
3.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quassinoidMembers of the class of triterpenoid, mostly isolated as bitter principles of the Simaroubaceae family. They are chemically regarded as degraded triterpenes and can be categorized into groups with C18, C19, C20, C22 and C25 skeletons.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID337705Antimalarial activity as reduced parasitaemia at day 4 against Plasmodium berghei N infected TSW mice (Mus musculus) at 9 mg/kg perorally dosed 3 hrs post infection then daily
AID1707241Antiproliferative activity against human HT-29 cells2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID417078Cytotoxicity against human Lu1 cells after 2 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.
AID1707245Cytotoxicity against human MCF-7 cells incubated for 72 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1707242Antiproliferative activity against human HeLa cells2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1707246Cytotoxicity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID337704Antimalarial activity as reduced parasitaemia at day 4 against Plasmodium berghei N infected TSW mice (Mus musculus) perorally dosed 3 hrs post infection then daily
AID1707171Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by WST-1 assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID311567Antibabesial activity against Babesia gibsoni2007Journal of natural products, Oct, Volume: 70, Issue:10
Screening of Indonesian medicinal plant extracts for antibabesial activity and isolation of new quassinoids from Brucea javanica.
AID417080Cytotoxicity against human MCF7 cells after 2 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.
AID417082Ratio ED50 for human MCF7 cells to ED50 for human MCF7 cells in presence of 43 uM (-)-hydnocarpin2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.
AID337702Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected human erythrocytes assessed by [3H]hypoxanthine uptake
AID1918735Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as inhibition of viral propagation preincubated for 1 hrs followed by viral infection and measured after 24 hrs by qRT-PCR analysis2022Journal of natural products, 12-23, Volume: 85, Issue:12
Evaluating the
AID417081Cytotoxicity against human MCF7 cells after 2 days by sulforhodamine B assay in presence of 43 uM (-)-hydnocarpin2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.
AID417079Cytotoxicity against hormone-dependent human LNCAP cells after 2 days by sulforhodamine B assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.
AID1707191Antiproliferative activity against human HL-60 cells2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's0 (0.00)18.2507
2000's3 (18.75)29.6817
2010's4 (25.00)24.3611
2020's7 (43.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.49 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.88%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]